Showing results (91-100 of 99) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2015
The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesionsThomas T Tapmeier, Anna Moshnikova, John Beech, et al.Frontiers in Urology|November 28, 2022
Targeting Bladder Urothelial Carcinoma with pHLIP-ICG and Inhibition of Urothelial Cancer Cell Proliferation by pHLIP-amanitinAnna Moshnikova, Borivoj Golijanin, Ali Amin, et al.Proceedings of the National Academy of Sciences of the United States of America|August 16, 2017
Two transmembrane dimers of the bovine papillomavirus E5 oncoprotein clamp the PDGF β receptor in an active dimeric conformationAlexander G Karabadzhak, Lisa M Petti, Francisco N Barrera, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 2016
Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex vivoJovana Golijanin, Ali Amin, Anna Moshnikova, et al.Nature|November 20, 2014
MicroRNA silencing for cancer therapy targeted to the tumour microenvironmentChristopher J Cheng, Raman Bahal, Imran A Babar, et al.Bioconjugate Chemistry|July 12, 2016
PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization StudyDustin Wayne Demoin, Linden C Wyatt, Kimberly J Edwards, et al.Proceedings of the National Academy of Sciences of the United States of America|May 3, 2014
Understanding the pharmacological properties of a metabolic PET tracer in prostate cancerNerissa Therese Viola-Villegas, Sean D Carlin, Ellen Ackerstaff, et al.NAR Cancer|December 10, 2021
Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'Sophia Gayle, Robert Aiello, Nalin Leelatian, et al.NAR Cancer|July 28, 2021
Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicitySophia Gayle, Robert Aiello, Nalin Leelatian, et al.Pageof 10